These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7955379)

  • 41. Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
    Huber PR; Zaugg T; Linder E; Hagmaier V; Rutishauser G
    Urol Res; 1982; 10(2):75-80. PubMed ID: 6180539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The significance of creatine kinase (CKBB) in metastatic cancer of the prostate.
    Forman DT
    Ann Clin Lab Sci; 1979; 9(4):333-7. PubMed ID: 485095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Creatine kinase isoenzyme (CK-BB) by RIA as a follow-up marker in stage D cancer of the prostate: comparison with PAP RIA.
    El-Shribiny A; Bharvaga A; Fitzpatrick J; Murphy GP
    J Surg Oncol; 1985 Mar; 28(3):232-6. PubMed ID: 3974250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Creatine kinase and lactate dehydrogenase isoenzyme patterns in cultured normal and pathological gingival fibroblasts.
    Huang JS; Liu TZ; Bhatnagar RS
    J Formos Med Assoc; 1990 Feb; 89(2):126-31. PubMed ID: 1973720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presence of creatine kinase BB isoenzyme in some patients with prostatic carcinoma.
    Feld RD; Witte DL
    Clin Chem; 1977 Oct; 23(10):1930-2. PubMed ID: 902421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creatine kinase BB and other markers of prostatic carcinoma.
    Silverman LM; Chapman JF; Jones ME; Dermer GB; Pullano T; Tökes ZA
    Prostate; 1981; 2(1):109-19. PubMed ID: 7024960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.
    Waguespack SG; Hui SL; White KE; Buckwalter KA; Econs MJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2212-7. PubMed ID: 11994366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical localization of creatine kinase BB in primary breast cancer: correlation with estrogen receptor content.
    Scambia G; Santeusanio G; Panici PB; Iacobelli S; Mancuso S
    J Cancer Res Clin Oncol; 1988; 114(1):101-4. PubMed ID: 3350836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioluminescence assay of creatine kinase and its isoenzymes in serum and cerebrospinal fluid.
    Tarkkanen P; Komor S; Cornely C; Hacke W; Greiling H
    Clin Chem; 1979 Sep; 25(9):1644-8. PubMed ID: 466791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease.
    Bell RD; Rosenberg RN; Ting R; Mukherjee A; Stone MJ; Willerson JT
    Ann Neurol; 1978 Jan; 3(1):52-9. PubMed ID: 655654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzymic, electrophoretic and immunoreactive properties of labeled MM and BB isoenzymes of human creatine kinase.
    Fang VS; Cho HW; Meltzer HY
    Enzyme; 1978; 23(3):210-4. PubMed ID: 738260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Creatine kinase isoenzymes in acute brain injury.
    Kaste M; Hernesniemi J; Somer H; Hillbom M; Konttinen A
    J Neurosurg; 1981 Oct; 55(4):511-5. PubMed ID: 7276998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unexplained increase in serum creatine kinase isoenzyme MB activity in a lung cancer patient.
    Goffman T; Cantrell J; Schein P
    Clin Chem; 1981 Dec; 27(12):2068-9. PubMed ID: 6273014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of creatine kinase isoenzyme BB as a marker of neoplastic growth in Yoshida ascites hepatoma of the rat.
    Neri B; Bartalucci S; Romano S; Ciapini A
    Anticancer Res; 1985; 5(5):533-6. PubMed ID: 4062255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The production of creatine kinase isozyme BB in sera of a patient with prostatic carcinoma and in tumor homogenates.
    Hoag G; Amies DR; Colquhoun BD
    Clin Biochem; 1978 Apr; 11(2):38-41. PubMed ID: 647900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IgA-CK-BB complex with CK-MB electrophoretic mobility can lead to erroneous diagnosis of acute myocardial infarction.
    Venta R; Geijo SA; Sánchez AC; Bao CG; Bartolome LA; Casares G; Lopez-Otin C; Alvarez FV
    Clin Chem; 1989 Sep; 35(9):2003-8. PubMed ID: 2776341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creatine kinase isoenzyme BB in serum of patients undergoing chronic hemodialysis and with kidney transplant.
    Jung K; Scholz D; Precht K
    Enzyme; 1979; 24(3):169-72. PubMed ID: 387410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions.
    Schwartz JG; Bazan C; Gage CL; Prihoda TJ; Gillham SL
    Clin Chem; 1989 Apr; 35(4):651-4. PubMed ID: 2702750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis.
    Caux F; Chosidow O; Philippon C; Roujeau JC; Revuz J
    Br J Dermatol; 1994 Mar; 130(3):337-41. PubMed ID: 8148275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
    Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.